Fosaport 150 mg Injection
29.88$
9.15$
Fosaport 150 mg injection is an effective treatment designed to help prevent nausea and vomiting, particularly in patients undergoing chemotherapy, including both adults and children as young as six months. This medication works synergistically with other antiemetic agents to provide relief from these distressing side effects associated with cancer treatment. While generally well-tolerated, some patients may experience common side effects such as fatigue, diarrhea, and anemia. It's essential to be aware of potential warnings, including the risk of neutropenia, dyspepsia, peripheral neuropathy, and urinary tract infections. As with any medication, it’s crucial to discuss your complete medical history and any current medications with your healthcare provider before starting Fosaport. By effectively managing nausea and vomiting, Fosaport can enhance the overall treatment experience for patients undergoing chemotherapy. Always follow your healthcare provider's instructions to ensure safe and effective use of this medication.
الكمية
Active Pharmaceutical Ingredient
Uses
• Fosaport 150 mg injection is primarily utilized to prevent nausea and vomiting associated with chemotherapy treatments. Patients undergoing chemotherapy often experience severe gastrointestinal side effects, which can impact their overall treatment experience. By administering Fosaport 150 mg injection, healthcare providers can help patients manage these symptoms effectively. This support is crucial for maintaining patients' quality of life during their cancer treatment.
• In addition to its role in chemotherapy, Fosaport 150 mg injection can be beneficial for patients receiving certain types of surgery. Anesthesia and surgical procedures can trigger nausea and vomiting, which may complicate recovery. Fosaport 150 mg injection works by targeting the pathways that induce these symptoms, thereby enhancing postoperative recovery. This makes it a valuable tool in the perioperative care of patients.
• Fosaport 150 mg injection is also indicated for patients who have previously experienced nausea and vomiting during chemotherapy cycles. For individuals with a history of severe reactions, proactive administration of Fosaport can be a key part of their treatment regimen. This preventive approach can significantly reduce the likelihood of these distressing symptoms occurring. As a result, patients can focus more on their recovery and less on managing side effects.
• Furthermore, Fosaport 150 mg injection can be part of a comprehensive antiemetic regimen for patients undergoing multiple cycles of chemotherapy. As treatment progresses, the risk of nausea and vomiting may increase, necessitating additional support. By incorporating Fosaport 150 mg injection into their care plan, oncologists can provide tailored symptom management. This ensures that patients receive consistent and effective support throughout their treatment journey.
Benefits
Fosaport 150 mg Injection is a highly effective solution for nausea and vomiting often associated with chemotherapy. This product successfully prevents these distressing symptoms by inhibiting the activity of substance P, a neurotransmitter responsible for triggering the vomiting reflex. As nausea and vomiting are common side effects of chemotherapy, their impact on a patient's quality of life can be significant. However, with the help of Fosaport 150 mg, patients can experience relief and an overall improvement in their well-being. Not only does it help patients recover more comfortably from cancer treatments such as radiotherapy or chemotherapy, but it has also been shown to be very effective in preventing nausea and vomiting following surgery (only in adults). It is important to note that Fosaprepitant Injection 150 mg should only be administered by a healthcare professional and not by the patient themselves.
Side Effects
As with all medicines, Fosaprepitant Injection 150 mg may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Most Common Side Effects
• Tiredness
• Weakness
• Headache
• Heartburn
• Numbness, weakness, tingling, or pain in legs or arms
• Diarrhoea
• Indigestion
• Fever
• Redness, itching, hardness, swelling, or pain at the injection site
Common Side Effects
• Painful or frequent urination
• Trouble swallowing or breathing
• Low blood cell count
• Unusual bleeding
• Fast or weak heartbeats
• Hives
• Itching
• Rash
• Skin Sores or Peeling
• Dizziness
• Swelling
How To Use
Anti-nausea Drug Fosaport administered intravenously (into a vein) comes as a powder and is to be mixed with liquid by a health care professional, nurse or doctor in a medical facility. It is given for 1 time on the first day of a cancer chemotherapy treatment cycle. The frequency and dosage of Fosaport 150 mg Vial injection is decided by your health care professional or doctor. You should inform your health care, professional or doctor if you face any serious side effects.
Safety Advice
• Alcohol: Avoiding alcohol consumption is advised when taking Fosaport 150 mg Injection to reduce the risk of liver damage. It is best to refrain from drinking alcohol while on any medication.
• Kidney: Patients with kidney disease can safely use Fosaport 150 mg. No dose adjustment of Fosaport 150 mg is necessary.
• Breastfeeding: Breastfeeding while on Fosaport 150 mg Vial is not recommended as it may harm the infant. Consult your doctor to discuss the potential risks and benefits of continuing to breastfeed while taking Fosaport Injection. Your doctor can help you make an informed decision for the health of both you and your baby.
• Liver: Patients with liver disease should exercise caution when using Fosaport 150 mg Injection. It is crucial for individuals with liver disease to closely observe their liver function while using Fosaport 150 mg and promptly inform their physician of any abnormal symptoms or changes in liver function. Adjustments to the dosage of Fosaprepitant Injection 150 mg may be necessary for patients with liver disease.
• Pregnancy: There is a lack of sufficient and properly conducted studies on pregnant women. The use of Fosaport Injection during pregnancy should only be considered if the potential benefits outweigh the potential risks to both the mother and the fetus.
• Driving: The usage of Fosaprepitant Injection 150 mg can lead to symptoms like dizziness, fatigue, and impaired concentration and coordination, which can potentially compromise your driving skills. To ensure your safety, it is crucial to adhere to your doctor's guidance and take necessary precautions, such as refraining from driving or operating heavy machinery if you experience any of these side effects caused by Fosaport 150 mg.